Jeune Aesthetics, a subsidiary of Krystal Biotech, announced positive results from its PEARL-2 Phase 1 study of KB304, an investigational therapy for treating wrinkles in the décolleté area. The study ...
–All primary and secondary endpoints were met for both Phase 3 studies (M21-500 and M21-508). –Results support BoNT/E as a novel botulinum neurotoxin serotype E characterized by a rapid onset of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback